Does SOX-2 expression have a prognostic value in triple-negative breast cancer?

Ismail Guzelis1, Betul Bolat Kucukzeybek2, Merve Gursoy3

  • 1Pathology Department, Izmir Buca Seyfi Demirsoy Training and Research Hospital, Izmir, Turkey.

Summary

SRY-box transcription factor 2 (SOX-2) expression was evaluated in triple-negative breast cancer (TNBC). SOX-2 was not significantly associated with survival outcomes in this cohort, suggesting larger studies are needed.